Please assess the completion status of the following clinical trial:

Trial Title: Repeated Voluntary Drug Intoxication (IMVr): Characterization of a New Addictive Behavior by Clinical Phenotyping and Functional Imaging

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~Will be offered for study subjects that meet the following criteria:~* Man or woman hospitalized (e) in the aftermath of a IMV:~  * History of at least 2 for the IMV group IMVr~ * First suicide attempt high intentionality (SIS score\> 20/30) for group IMVS~* Man or woman with alcohol dependence according to DSM-IV-TR, in the aftermath of withdrawal (outpatient or inpatient) for the alcohol group~* Man or woman free from any addictive disorder, suicidal or mood for the control group~And all of the following criteria:~* Age greater than or equal to 18 and less than or equal to 60 years~* Informed consent in writing signed by the patient~* Person affiliated to the social security or beneficiary of such a scheme~Exclusion Criteria:~For IMVS Group:~* Have a history of scarification or addictive disorder (behavioral or product)~In the alcohol group:~* TS present history~For all patients, presenting at least one of the following criteria:~* Age less than 18 years, over 60 years.~* acute or chronic delusional disorder.~* Cognitive impairment or impeding the reading comprehension quizzes.~* secondary pathologies at a stroke.~* Denial of participation.~* Contraindications to MRI.~* Subjects with clinically significant gastrointestinal, renal, hepatic, endocrine, cardiovascular or respiratory (especially persistent asthma) which can prevent stay of 60 min in MRI without being hindered.~* No participant to another pharmacological study.~* unauthorized treatments: all psychotropic treatments (except anti-anxiety treatments benzodiazepine average duration of action and antihistamine), baclofen and other treatment can modify vasoreactivity fMRI.~* Coagulation disorders against-indicating blood.~* People under guardianship

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Volunteers repeated drug poisoning (Type: EXPERIMENTAL): performing MRI and a biological assessment
- Volunteers single drug poisoning (Type: OTHER): performing MRI and a biological assessment
- alcoholic (Type: OTHER): performing MRI and a biological assessment
- volunteers (Type: OTHER): performing MRI and a biological assessment

Based on this trial design, predict the completion outcome and termination type (if applicable).